IR415
IR415 is a potent anti-HBV agent and inhibits HBV replication by blocking the HBx activity. IR415 selectively interacts with HBx (Kd=2 nM) and blocks HBV-mediated RNAi suppression, reverses the inhibitory effect of HBx protein on the activity of the dicer endoribonuclease[1]. HBx: hepatitis B virus X protein.
Product Specifications
CAS Number
452967-14-5
UNSPSC
12352005
Target
HBV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/ir415.html
Purity
99.66
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
S=C(NCCCN1C=CN=C1)NC2=CC=C(F)C=C2F
Molecular Formula
C13H14F2N4S
Molecular Weight
296.34
References & Citations
[1]Ghosh S, et al. An RNAi-based high-throughput screening assay to identify small molecule inhibitors of hepatitis B virus replication.J Biol Chem. 2017 Jul 28;292 (30) :12577-12588.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AP20297PU-N 100 µg
Alpha B Crystallin (CRYAB) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 
BNC471516-100 1x 100 µL
FOXA1 / HNF3A (FOXA1/1516), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
RC-15822-02 100 µL
Recombinant Fructose 6 Phosphate Kinase Antibody
Sign In for Pricing
View Details 
E-MSEL-M0008-01 10x 96 Tests
Mini Sample Mouse IL-4 (Interleukin 4) ELISA Kit
Sign In for Pricing
View Details